...
机译:CYP2C9,VKORC1和CYP4F2多态性和儿科华法林维持剂量:系统评价和荟萃分析
Hosp Sick Children Div Clin Pharmacol &
Toxicol Toronto ON Canada;
Hosp Sick Children Div Clin Pharmacol &
Toxicol Toronto ON Canada;
Newcastle Univ Inst Cellular Med Newcastle Upon Tyne Tyne &
Wear England;
Newcastle Univ Inst Cellular Med Newcastle Upon Tyne Tyne &
Wear England;
Nationwide Childrens Hosp Div Pediat Hematol Oncol BMT Columbus OH USA;
Vanderbilt Univ Med Ctr Dept Pediat Monroe Carell Jr Childrens Hosp Vanderbilt Div Pe Nashville;
Hop Necker Enfants Malad AP HP Unite Med Chirurg Cardiol Congenitale &
Pediat Ctr Reference M3C;
Univ Paris 05 INSERM Unite Mixte Rech UMR S Paris France;
BC Ctr Dis Control Influenza &
Emerging Resp Pathogens Vancouver BC Canada;
Univ British Columbia Div Translat Therapeut Dept Pediat Vancouver BC Canada;
Uppsala Univ Dept Med Sci Clin Pharmacol &
Sci Life Lab Uppsala Sweden;
Uppsala Univ Dept Med Sci Clin Pharmacol &
Sci Life Lab Uppsala Sweden;
Toyama Univ Grad Sch Med &
Pharmaceut Sci Dept Pediat Toyama Japan;
Toyama Univ Grad Sch Med &
Pharmaceut Sci Toyama Japan;
Yokohama City Univ Sch Med Dept Pediat Yokohama Kanagawa Japan;
Yokohama City Univ Sch Med Dept Pediat Yokohama Kanagawa Japan;
Univ Shizuoka Sch Pharmaceut Sci Dept Clin Pharmacol &
Genet Shizuoka Japan;
Univ Shizuoka Sch Pharmaceut Sci Dept Clin Pharmacol &
Genet Shizuoka Japan;
Hosp Sick Children Div Pediat Hematol Oncol Toronto ON Canada;
Hosp Sick Children Div Clin Pharmacol &
Toxicol Toronto ON Canada;
机译:CYP2C9,VKORC1和CYP4F2多态性和儿科华法林维持剂量:系统评价和荟萃分析
机译:CYP2C9,VKORC1和CYP4F2多态性对18岁以下儿童华法林维持剂量的影响:系统评价和荟萃分析的方案
机译:CYP2C9,VKORC1和CYP4F2对少于18岁的儿童华法林维持剂量的影响; 系统审查和荟萃分析。
机译:CYP4F2 V433M多态性和华法林剂量
机译:当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系:基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
机译:CYP2C9VKORC1和CYP4F2多态性对18岁以下儿童华法林维持剂量的影响:系统评价和荟萃分析的方案
机译:CYP2C9,VKORC1和CYP4F2多态性对18岁以下儿童华法林维持剂量的影响:系统评价和荟萃分析的方案